Remote Patient Monitoring
![](https://cdn.prod.website-files.com/63f6c0d2675ee198a17d310a/644a8553d3b7d1a327283fb0_Medable-ecoa-person-on-phone-home-remote-dct.jpg)
![](https://cdn.prod.website-files.com/63f6c0d2675ee198a17d310a/64482e8f985430a5be0f547f_medable-man-reclining-reading-ipad-article-patient-centricity.jpg)
Blog posts
Why the future looks bright for eCOA in clinical trials
eCOA
6 min
See why the electronic clinical outcome (eCOA) market is poised to continue its rapid growth and why Medable customers have chosen eCOA as a future foundation for their next era of clinical conduct.
Speakers
No items found.
![woman on televisit](https://cdn.prod.website-files.com/63f6c0d2675ee198a17d310a/64527f3576b5be2281d00729_medable-oncology-case-study.jpg)
![](https://cdn.prod.website-files.com/63f6c0d2675ee198a17d310a/645acebd4c26031990557a26_ben-kolde-t9DooibgMEk-unsplash.jpg)
White Papers, Case Studies, Reports
ePRO Case study: Better options and outcomes oncology trials.
Oncology
6 min
Medable worked with a top 5 pharma company to increase the safety of patients as anti-cancer treatments may cause pulmonary toxicity, ranging from asymptomatic radiological changes to respiratory failure, and is considered a common side effect.